Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Internal Medicine
Reference28 articles.
1. Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: a Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(25):e1082–143.
2. Cardoso R, Blumenthal RS, Kopecky S, et al. How low to go with lipid-lowering therapies in a cost-effective and prudent manner. Mayo Clin Proc. 2019;94(4):660–9.
3. Lloyd-Jones DM, Morris PB, Ballantyne CM, et al. 2017 focused update on the 2016 ACC expert consensus decision pathway on the role of non-statin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol. 2017;70(14):1785–822.
4. Repatha® [package insert]. Thousand Oaks, CA: Amgen Inc; 2019.
5. Praluent® [package insert]. Bridgewater, NJ: Sanofi-aventis U.S. LLC; 2019.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献